GAiT discusses Quality and Standards for efficient iPSC Therapeutic Development at Biotechne's 2nd ATMP Virtual Symposium. Join live Q&A or listen to recording here. https://info.bio-techne.com/WBNBIO-TECHNE-2020-07webinar-AnalysingATMPS_LP-webinar-main.html
@HCATS_CDMO @IPSCtherapies @PaceLabs @synthace @CCRM_ca @ProteinSimple https://twitter.com/biotechne/status/1278725382695538689
Fate Therapeutics (@FateThx) has received FDA clearance of their IND application for the first-ever #iPSC-derived CAR T-Cell Therapy.
Congratulations to Susan Solomon, GAiT Director and CEO of @NYSCF, for winning the @ISSCR Stem Cell Public Service Award
Susan L. Solomon Receives Public Service Award From International Society for Stem Cell Research - New York Stem Cell Foundation
NYSCF CEO Susan L. Solomon recently received the 2020 Public Service Award from the International Society for Stem Cell...
GAiT wishes to express our condolences to @Simon_H_Ellison's family after he passed today after a brave fight with cancer.
ISCT2020, initially planned as a traditional conference in Paris, will now be held as virtual meeting instead on the same dates.
ISCT transitions to a virtual conference amidst coronavirus concerns
The International Society for Cell and Gene Therapy (ISCT; BC, Canada) has decided to alter their globally attended conference (27–30 May 2020, Pari...
GAiT employees are working from home because of the COVID-19 outbreak but are still contactable through the usual numbers and emails.
GAiT had planned to hold a Quality Workshop to dovetail ISCT2020 in Paris this year. Because of the COVID-19 epidemic, this will now be delayed until later in the year.
New infographic on @RegMedNet detailing quality control guidelines for clinical iPSCs. Check it out here: http://bit.ly/32SyScc
Regenerative Medicine's infographic showing recommended standards for clinical grade iPSCs for therapeutic development is now online:
Minimum standards for clinical iPSCs: what the experts suggest
In this infographic, we summarize key clinical standards suggested by the experts involved in the GAiT global banking network, as described in their R...
Scripting of the Quality Round manuscript is ongoing but has been delayed by the Corona virus outbreak. Thank you for your patience and once the manuscript is prepared, it will be circulated to Participants for comment/input.
GAiT Chairperson Prof Marc Turner will be speaking on GAiT activity in London 30th March - 1st April at the Terrapin 'Advanced Therapies Congress and Expo'
Research. Develop. Collaborate. Commercialise | Advanced Therapies
The global marketplace for investment, commercial opportunities and collaboration in the advanced therapies and regenerative medicine space.
A report released by the @CGTCatapult states that employment in the UK cell and gene therapy industry is set to double by 2024 the report indicates there are concerns over how demand will be met; primarily, the availability of targeted academic courses
Demand for ‘specialist skills’ in UK cell and gene therapy, says report
A skills demand report stated that employment in the UK cell and gene therapy industry is expected to double by 2024, with support of targeted courses...
GAiT will be speaking at the 'Translation and Innovation in induced Pluripotent Stem Cell Science' Workshop at Saïd Business School, Oxford on the 11th February 2020 and at the RESTORE meeting in Berlin on the 17th February 2020.
Osaka University transplants iPS cell-based heart cells in world's first clinical trial
Osaka University transplants iPS cell-based heart cells in world's first clinical trial | The Japan Times
An Osaka University team said it has carried out the world's first transplant of cardiac muscle cells created from iPS cells in a physician-initiated ...
Who would have thought 5 years ago that GSK, BMS, Gilead, Pfizer, Roche, J&J, Takeda, Astellas, Vertex... - will become the major cell-gene therapy companies? The craze for acquisitions will continue in 2020. Pharma/Biotech will eat them all!